The KOMET trial, the largest global placebo-controlled trial in the patient group to date, showed that Koselugo can reduce ..
BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback